Skip to main content
. 2013 Jan 24;8(1):e51460. doi: 10.1371/journal.pone.0051460

Table 1. Invasive Pneumococcal Disease in Children Younger than 5 years after the introduction of the Heptavalent Pneumococcal Conjugate Vaccine in Denmark.

PCV7 serotypes Non-Vaccinated PCV7-vaccinated3 Total
Eligible1 Non-eligible2
4 0 0 0 0
6B 9 2 0 11
9V 2 0 0 2
14 7 2 4 13
18C 0 6 1 7
19F 1 3 3 7
23F 0 3 2 5
all 19 (42%) 16 (36%) 10 (22%) 45 (100%)
Additional serotypes in PCV13
1 1 12 12 25
3 2 1 2 5
5 0 0 1 1
6A 3 2 5 10
7F 2 15 29 46
19A 2 2 14 18
all 10 (10%) 32 (30%) 63 (60%) 105 (100%)
Other serotypes 4 16 (42%) 0 22 (58%) 38 (100%)
PCR 2 (67%) 1 (33%) 0 3 (100%)
Total 47 49 95 191
1

Eligible: child within the age group targeted for primary PCV7/PCV13 vaccination or catch-up program who presented an IPD episode before vaccination.

2

Not-eligible: child outside the age group targeted for primary PCV7/PCV13 vaccination or catch-up program with PCV7.

3

PCV7-vaccinated: children who presented an IPD episode after PCV7 immunization, regardless of the number of doses received, the time of onset of illness after vaccination and the age of immunization.

4

Other serotypes: 6C, 8, 10B, 12F, 15B/C, 16F, 18F, 22F, 23F, 24F, 33F, 35B, 35F. No clear predominance of any serotype was observed. None of the patients presenting IPD due to PCV7 or PCV13 serotypes were vaccinated with PCV13.